Breaking News

Parexel Makes Key Leadership Appointments

Appointments focused on enhancing connections and collaboration to drive innovation across the next-gen delivery of clinical trials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Parexel, a global CRO, appointed Peyton Howell to the newly created role of Chief Operating and Growth Officer and Amy McKee, MD, as Chief Medical Officer and Global Head, Oncology Center of Excellence. These appointments aim to strengthen the company’s medical and scientific focus and support its growth through closer alignment of strategy, sales and delivery to customers.   As Chief Operating and Growth Officer, Ms. Howell will lead Parexel’s operational delivery, strategy and growth. She jo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters